Genentech’s crovalimab meets co-primary efficacy endpoints in phase 3 PNH study

By NS Healthcare Staff Writer

08 Feb 23

Results of the late-stage study demonstrated that crovalimab administered as a subcutaneous injection every four weeks, controlled the…

Patient CarePharmaceuticals and Medicines

Takeda receives FDA nod for TAKHZYRO to prevent HAE attacks in children

By NS Healthcare Staff Writer

06 Feb 23

The approval is backed by efficacy data from the phase 3 HELP study with additional data from the…

Patient CarePharmaceuticals and Medicines

BioNTech completes construction of plasmid DNA plant in Germany

By NS Healthcare Staff Writer

03 Feb 23

The company anticipates investing nearly €40m in the new plasmid DNA manufacturing facility

Patient CarePharmaceuticals and Medicines

Amgen announces US roll-out of first biosimilar to Humira

By NS Healthcare Staff Writer

01 Feb 23

Amjevita will be offered in a citrate-free formulation to reduce pain at the injection site and will be…

Patient CarePharmaceuticals and Medicines

Japan’s MHLW grants priority review status for Eisai-Biogen’s Lecanemab

By NS Healthcare Staff Writer

30 Jan 23

Lecanemab is an Aβ protofibril antibody, which is approved in the US for the treatment of Alzheimer’s disease…

Patient CarePharmaceuticals and Medicines

Bristol Myers’ Breyanzi meets primary endpoint in TRANSCEND CLL 004 trial

By NS Healthcare Staff Writer

27 Jan 23

The TRANSCEND CLL 004 trial evaluated the CAR T cell therapy in patients with relapsed or refractory chronic…

Patient CarePharmaceuticals and Medicines

Sandoz to acquire antifungal agent Mycamine from Astellas

By NS Healthcare Staff Writer

24 Jan 23

The addition of Mycamine is expected to considerably strengthen Sandoz’s hospital offering, anti-infective portfolio, and a global programme…

Patient CarePharmaceuticals and Medicines

Genexine gets Korean fast track status for GX-188E for advanced cervical cancer

By NS Healthcare Staff Writer

23 Jan 23

South Korea's MFDS determined that GX-188E met the requirements for fast track status after reviewing data from a…

Patient CarePharmaceuticals and Medicines

Sun Pharma to buy US-based Concert Pharmaceuticals for $576m

By NS Healthcare Staff Writer

20 Jan 23

Concert Pharmaceuticals’ deuruxolitinib is an oral inhibitor of Janus kinases JAK1 and JAK2, which is currently in late-stage…

Patient CarePharmaceuticals and Medicines

Bio-Thera’s Actemra biosimilar BAT1806 secures China NMPA’s approval

By NS Healthcare Staff Writer

17 Jan 23

BAT1806 has been indicated for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, and cytokine release syndrome

Patient CarePharmaceuticals and Medicines